Position in BMY
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$2,043,320
-$92,045 QoQ
Shares Held
35,462
+0.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#830
of 2,506 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026RFG Advisory, LLC holds $46,810,911 across 13 Drug Manufacturers - General names. BMY ranks #7 (4.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
10,775 | $12,923,859 | |
| 2 | ABBV |
AbbVie Inc.
|
40,584 | $10,212,557 | |
| 3 | JNJ |
Johnson & Johnson
|
22,980 | $5,836,230 | |
| 4 | AMGN |
Amgen Inc
|
14,031 | $5,080,905 | |
| 5 | NVO |
Novo Nordisk A S
|
66,135 | $3,170,511 | |
| 6 | MRK |
Merck & Co., Inc.
|
20,666 | $2,655,581 | |
| 7 | BMY |
Bristol Myers Squibb Co
This page
|
35,462 | $2,043,320 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
12,955 | $1,636,734 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,043,320 | 35,462 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $2,135,365 | 35,208 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $1,823,010 | 33,797 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $1,099,763 | 24,385 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,238,812 | 26,762 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $1,702,535 | 27,915 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $944,947 | 16,707 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $889,462 | 17,191 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $785,623 | 18,917 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $1,205,749 | 22,234 | Shares | Sole | 2024-04-11 | |
| 2023-12-31 | $924,400 | 18,016 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $983,894 | 16,952 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $953,238 | 14,906 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $1,068,898 | 15,422 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $1,099,755 | 15,285 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $1,192,748 | 16,778 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,173,711 | 15,243 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $1,200,832 | 16,443 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $999,034 | 16,023 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $768,204 | 12,983 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $883,694 | 13,225 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $822,331 | 13,026 | Shares | Sole | 2021-04-19 | |
| 2020-12-31 | $814,267 | 13,127 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $771,410 | 12,795 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $763,576 | 12,986 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $687,552 | 12,335 | Shares | Sole | 2020-04-17 | |
| No filing history on record for this holder in this stock. | ||||||